Important Safety Information For Patients

Do not take KAPVAY® if you are allergic to clonidine.

● Use KAPVAY® with caution if you have high or low blood pressure, kidney problems, or heart problems, including heart attacks or strokes. You should avoid becoming dehydrated or overheated when taking KAPVAY®

Safety Information Continued Below

What is KAPVAY®?
KAPVAY® is a non-stimulant medication for treating your child’s ADHD
    Learn about the differences between stimulants and non-stimulants
  • Stimulants are the best known and most widely used treatments
  • Non-stimulants were approved to treat ADHD more recently. They can either be prescribed alone or in combination with a stimulant for additional improvement

KAPVAY® is not a central nervous system (CNS) stimulant
    KAPVAY® may be used alone or with a stimulant
  • KAPVAY® may have been prescribed as a single medication to treat your child’s ADHD
    • KAPVAY® alone has been proven to improve ADHD symptoms
  • KAPVAY® may have been added to your child’s current stimulant medication
    • KAPVAY® is proven to help improve ADHD symptoms better than a stimulant alone
    • What’s more, when KAPVAY® is added to a stimulant, the stimulant dose can be adjusted/lowered based on patient response
KAPVAY® has been proven to improve symptoms of inattentiveness and hyperactivity/impulsivity

KAPVAY® should be used as a part of a total treatment plan recommended by the doctor

Be confident in KAPVAY® because:

  • It is not a controlled substance
  • It has no known potential for abuse or dependence
  • It is easily refilled—over the phone, at the pharmacy, or through mail order





KAPVAY® is a registered trademark of
Concordia Pharmaceuticals Inc.
©2013 Concordia Pharmaceuticals Inc.
Bridgetown, Barbados, BB11128

All rights reserved.
Privacy Policy | Terms of Use
Contact Concordia Pharmaceuticals Inc.
For medical inquires, call 1-877-370-1142.
KAP-WWW-001 10/13
 
This website and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.